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Background: The use of capnography monitoring devices has been shown to lower the rates of 
hypoxemia via early detection of respiratory depression, and facilitate more accurate titration of 
sedatives during procedures. The aim of the current meta-analysis was to compare the incidence 
of hypoxemia associated with standard monitoring alone during gastrointestinal endoscopy to 
that associated with standard monitoring with the addition of capnography.
Methods: The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials 
scientific databases were searched to identify relevant studies. We performed a meta-analysis 
of randomized controlled trials undertaken up to January 2018 that met our predefined inclusion 
criteria. The study outcome measures were incidence of hypoxemia, severe hypoxemia, apnea, 
the use of assisted ventilation, the use of supplemental oxygen, and change in vital signs.
Results: We included nine trials assessing a total of 3,088 patients who underwent gastrointestinal 
procedural sedation. Meta-analysis of study outcome revealed that capnography significantly 
reduced the incidence of hypoxemia (odds ratio 0.61, 95% CI 0.49–0.77) and severe hypoxemia 
(odds ratio 0.53, 95% CI 0.35–0.81). However, there were no significant differences in other 
outcomes including incidence of apnea, assisted ventilation, supplemental oxygen, and changes 
in vital signs. Early procedure termination and patient satisfaction-related outcomes did not 
differ significantly in the capnography group and the standard monitoring group.
Conclusion: This study indicates that capnography monitoring is an important addition with 
regard to the detection of hypoxemia during gastrointestinal procedural sedation, and should 
be considered in routine monitoring during gastrointestinal endoscopy.
Keywords: endoscopy, additional monitoring, hypoxemia, apnea
Introduction
Sedation and analgesia are commonly used during gastrointestinal endoscopic 
procedures, and have been shown to increase the success rates of these procedures.1 
However, the use of sedative agents can result in respiratory depression, airway 
obstruction, hypoxemia, and adverse cardiopulmonary events.2,3 Therefore, monitoring 
of vital signs including continuous pulse oximetry combined with a patient’s breath-
ing pattern is advocated in many national guidelines on sedation for gastrointestinal 
endoscopy.4,5
Capnography measures the carbon dioxide (CO
2
) concentration throughout the 
respiratory cycle, which allows for real-time evaluation of a variety of respiratory 
factors including respiratory depression, apnea, and hypercapnia.6 Hypoventilation can 
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occur in the presence of normal arterial oxygen saturation 
as determined via pulse oximetry (SpO
2
), and inadequate 
ventilation can precede hypoxemia by several minutes.7,8 The 
use of a capnography monitoring device has been shown to 
lower the rates of hypoxemia via early detection of respi-
ratory depression and facilitate more accurate titration of 
sedatives during procedures.9
The American Society of Anesthesiologists recom-
mended that capnography monitoring should be considered 
for all patients receiving deep sedation.5 However, there 
are insufficient data to demonstrate that improved clinical 
outcomes or care quality derive from the use of capnogra-
phy in patients undergoing targeted moderate sedation for 
upper endoscopy and colonoscopy.4,10,11 Furthermore, it has 
been suggested that capnography may lead to unnecessary 
procedure interruption, delay, or termination, contributing 
to inefficiency.4 Thus, most guidelines for gastrointestinal 
sedation do not recommend routine use of capnography, but 
recommend it only in specific situations including high-risk 
patients, intended deep sedation, and long procedures such 
as endoscopic retrograde cholangiopancreatography (ERCP) 
and endoscopic ultrasonography (EUS).4,11,12
The aim of the current meta-analysis was to determine 
whether the addition of capnography to standard monitoring 
including pulse oximetry reduces hypoxemic events during 
gastrointestinal endoscopic sedation.
Methods
In this systematic review, determination of the criteria for the 
selection of studies, extraction of relevant data, assessment 
of study quality, and statistical analyses were conducted and 
reported in accordance with the Preferred Reporting Items for 
Systematic Review and Meta-Analyses statement.13
literature search
We conducted a systematic literature search using MEDLINE, 
EMBASE, and the Cochrane Central Register of Controlled 
Trials updated from 1979 to January 2018. The following 
Medical Subject Heading terms were used: “capnography”, 
“hypoxia”, “monitoring”, “physiologic”, “endoscopy”, 
“endoscopic”, “gastrointestinal”, “gastroscopy”, “gastro-
scopes”, “colonoscopy”, and “colonoscopes”. All of these 
items were then explored to include secondary headings, and 
the reports considered were limited to those involving human 
subjects. Two investigators (SHK and YSC) independently 
reviewed all potentially relevant material to determine 
whether or not it met the inclusion criteria.
inclusion and exclusion criteria and 
definitions
The inclusion criteria were as follows: 1) study population, 
patients undergoing gastrointestinal endoscopic sedation; 
2) intervention, capnography monitoring; control, standard 
monitoring; 3) outcome measure, the incidence of oxygen 
desaturation; and 4) study design, prospective and random-
ized controlled trials (RCTs). Duplicate publications, review 
articles, case reports, studies without raw data available for 
retrieval, and studies only available as abstracts from confer-
ences were excluded.
evaluation criteria for endpoints
The primary endpoint of this study was the weighted sum-
mary OR of the incidence of hypoxemia (SpO
2
 of ,90% 
to ,95%) with a 95% CI. The secondary endpoints were 
1) incidence of severe hypoxemia defined as SpO
2
 of ,85%; 
2) incidence of apnea; 3) early detection of apnea; 4) use 
of assisted ventilation; 5) use of supplemental oxygen; 
6) bradycardia; 7) hypotension; 8) incidence of early pro-
cedure termination; 9) patient satisfaction; and 10) patient 
cooperation with regard to the endoscopic procedure.
study selection and data extraction
After removing duplicate studies, two investigators (SHK 
and YSC) independently perused the titles and abstracts of 
all publications retrieved and assessed their eligibility for 
inclusion in the meta-analysis. If available, the full texts of 
selected studies were screened with reference to the inclu-
sion and exclusion criteria. Selected full-text articles were 
critically appraised for relevance and validity. When any 
disagreement occurred, this was resolved by discussion, 
together with clinical expert consultation. The following 
information was extracted from the articles included: first 
author, year of publication, endoscopic procedure, monitor-
ing intervention, patients’ baseline characteristics, sedative 
agents, depth of sedation, duration of procedures, and primary 
and secondary outcomes. To avoid bias in the data extraction 
process, two investigators (SHK and YSC) independently 
evaluated each study quality and compared results with one 
another. In case of disagreement, the third investigator (EK) 
made a determination decision.
assessment of methodological quality
The Cochrane Collaboration’s risk of bias tool was used to 
assess the risk of bias in all included studies. The following 
items were assessed and recorded: random sequence genera-
tion (selection bias), allocation concealment (selection bias), 
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blinding of participants and personnel (performance bias), 
blinding of outcome assessment (detection bias), incom-
plete outcome data (attrition bias), and selective reporting 
(reporting bias).
gRaDe assessment and summary 
of findings
We used the Grading of Recommendations Assessment, 
Development, and Evaluation (GRADE) approach to assess 
the quality of the evidence associated with specific outcomes 
(hypoxemia, severe hypoxemia, incidence of apnea, and 
detection of apnea) in our review and to construct a “sum-
mary of findings” table. The GRADE approach considers 
study risk of bias (methodological quality), directness of 
the evidence, heterogeneity of the data, precision of effect 
estimates, and risk of publication bias.
statistical analysis
All analyses were performed using Meta V.4.9–0 and 
Meta for V.2.0–0 in R packages (R language version 3.4.3; 
R Foundation for Statistical Computing, Vienna, Austria). 
We calculated the OR as a summary statistic with a 95% CI 
for dichotomous outcomes and the standardized mean differ-
ence with a 95% CI for continuous outcomes. Heterogeneity 
among the studies was measured using the I2 statistic and the 
P-value was derived from the Cochran’s Q test. Significant 
between-study heterogeneity was deemed to be present when 
there was an I2 value of more than 50% or a Cochran’s Q test 
P-value of ,0.1.14 The presence of publication bias was 
evaluated via Egger’s test with a funnel plot.15
Results
Identification of studies
Nine studies derived from eight RCTs6,7,9,16–20 in which a 
total of 3,088 patients who underwent gastrointestinal pro-
cedural sedation were enrolled were ultimately included in 
the final analysis (Figure 1). Overall, 1,542 patients were 
assigned to the capnography group, and the remaining 1,546 
were assigned to the standard monitoring group.
study characteristics and patient 
populations
Of the eight studies, four were performed in Germany, three 
were performed in the USA, and one was performed in 
Denmark. Endoscopic procedures included upper endoscopy, 
colonoscopy, EUS, ERCP, and other interventional proce-
dures. One study, published by Mehta et al,6 provided sepa-
rate data on colonoscopy and esophagogastroduodenoscopy. 
Five studies used propofol as a sedative agent7,9,18–20 and 
other studies used either fentanyl, midazolam, meperidine, 
or ketamine, or combination of these.6,16,17 The main charac-
teristics of the studies are presented in Table 1.
Apnea was defined as the absence of respiratory activity 
denoted by a flat line on the capnograph in 7 studies,6,7,9,16,17,19,20 
and hypoventilation was defined as a respiratory rate of less 
than or equal to 8/min in two studies.6,19 In another two 
studies,6,17 greater than a 75% reduction in the amplitude 
of the capnograph waveform compared with baseline 
for 5–10 seconds was defined as abnormal or disordered 
ventilation.
In five of the eight studies, the endoscopy team (phy-
sicians and nurses) was not blinded to the assignment of 
patients. Capnographic data were available for the capnogra-
phy group, but not for the standard monitoring group. In the 
other three studies,6,16,17 the endoscopy team was not aware of 
the capnographic findings, and capnographic data were only 
available to an independent observer. In these three studies, 
interventions were initiated in both groups based on capnog-
raphy, albeit at different intervals (5–10 seconds for abnormal 
ventilation in the capnography group and .30 seconds for 
apnea in the standard monitoring group).
The studies included in this meta-analysis utilized four 
types of capnography. The Capnostream 20 (Oridion Medical, 
Needham, MA, USA) was used in four studies, and the other 
four studies used Capnostream 20 (Covidien, Mansfield, MA, 
USA), Philips M4 with Microstream CO
2
 (Philips Medical 
Figure 1 Flow diagram of study searching and selection process.
Abbreviation: RCT, randomized controlled trial.
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Systems, Andover, MA, USA; Oridion), Microcap (Oridion), 
and Philips MP 20 monitor, respectively.
Quality of the included studies
The risks of performances and outcome assessment biases 
were substantial due to lack of blinding. In five studies, 
neither the patients nor the endoscopy team was blinded, 
and there were no independent observers for the outcome 
assessment. The overall quality of the studies was moderate 
to low using the GRADE approach. We have included the 
risk of bias and a summary of findings in Tables S1 and S2, 
respectively.
hypoxemia
All studies reported hypoxemia, with the definitions vary-
ing from SpO
2
 of ,90% to ,95%. The study by Lightdale 
et al16 was performed in pediatric patients, and the defini-
tion of hypoxemia was SpO
2
 ,95%, which was higher than 
that of the other studies. In another studies,6,7,9,17–20 SpO
2
 
of ,90%–,92% was the criterion for hypoxemia. Publica-
tion bias was assessed by Egger’s test with a funnel tunnel 
plot (P=0.691).
The analysis revealed that capnography significantly 
reduced the incidence of hypoxemia (OR 0.61, 95% 
CI 0.49–0.77) (Figure 2). Six studies reported severe hypox-
emia, defined as SpO
2
 of ,85%. The analysis showed that the 
addition of capnography to standard monitoring has benefit 
in reducing the incidence of severe hypoxemia (OR 0.53, 
95% CI 0.35–0.81) (Figure 3).
apnea
Apnea was assessed with capnography in four studies, and 
the incidence of apnea was comparable between the two 
groups (OR 0.74, 95% CI 0.39–1.43) (Figure 4). In these 
four studies, capnography was used to detect apnea in both 
groups. In three studies, the endoscopy team was unaware 
of the capnographic findings, and apnea was assessed by an 
independent observer. In the remaining study, the endoscopy 
team was not blinded to the capnographic findings, and the 
incidence of apnea was retrospectively analyzed in the stan-
dard monitoring group.
In another two studies, apnea was more frequently 
detected in the capnography group than in the control 
group (OR 44.76, CI 25.35–79.04) (Figure 5). In these two 
studies, capnography was only used in the capnography 
group and was not used to detect apnea in the standard 
monitoring group.
Table 1 The main characteristics of the studies included in the meta-analysis
Study 
(publication year)
Number 
(cap, control)
Population 
and procedures
Sedatives, depth 
of sedation
Duration of procedures 
(cap vs control, minute)
Definition 
of hypoxemia
lightdale et al 
(2006)16
163 (83, 80) asa 1–2, children 
(0–19 years), endoscopy and 
colonoscopy
Fentanyl and midazolam, 
moderate
endoscopy: 10 (0–24) vs 
10 (4–25), colonoscopy: 
39 (34–67) vs 40 (15–69)
saO2 ,95% 
for 5 seconds
Qadeer et al 
(2009)17
247 (124, 123) asa 1–3, adults, eRCP or eUs Midazolam in combination 
with meperidine or 
fentanyl, n/a
37.2 (16.1) vs 34.4 (12.5) saO2 ,90% 
for 15 seconds
Beitz et al (2012)7 757 (383, 374) asa 1–3, adults, colonoscopy Propofol, adequate 35.9 (22.0) vs 33.8 (20.6) Fall in saO2 
$5% or ,90%
slagelse et al 
(2013)18
540 (263, 277) asa 1–3, adults, endoscopy 
or colonoscopy
Propofol, n/a 23.6 (12–30) vs 24 (13–31) saO2 ,92%
Friedrich-Rust et al 
(2014)19
533 (267, 266) asa 1–3, adults, colonoscopy 
alone or in combination with 
egD
Propofol in combination 
with ketamine, n/a
38 (16) vs 38 (17) saO2 ,90% 
for 15 seconds
Klare et al (2016)9 238 (108, 115) asa 1–4, adults, eRCP Propofol and midazolam, 
deep
38 (6–165) vs 38 (5–164) saO2 ,90%
Mehta et al (2016)6 209 (101, 108) asa 1–2, adults, endoscopy Fentanyl or midazolam 
or meperidine, moderate
5.6 (2.6) vs 5.6 (2.6) saO2 ,90% 
for 10 seconds
Mehta et al (2016)6 231 (117, 114) asa 1–2, adults, colonoscopy Fentanyl or midazolam 
or meperidine, moderate
17.3 (7.3) vs 17.4 (7.5) saO2 ,90% 
for 10 seconds
Riphaus et al 
(2017)20
170 (83, 87) asa 1–3, adults, interventional 
endoscopy (eUs or other 
interventional procedures)
Midazolam and propofol, 
adequate
25 vs 26 saO2 ,90%
Notes: Duration of procedures are presented as mean (sD) or median (interquartile range).
Abbreviations: cap, capnography; asa, american society of anesthesiologists; eRCP, endoscopic retrograde cholangiopancreatography; eUs, endoscopic ultrasonography; 
egD, esophagogastroduodenoscopy; n/a, not applicable; saO2, oxygen saturation.
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assisted ventilation and supplemental 
oxygen
Five studies reported on the use of assisted ventilation, and 
there was no evidence of heterogeneity (I2=0%). The fixed 
effect model demonstrated that the need to provide assisted 
ventilation was comparable between the two groups (OR 0.56, 
95% CI 0.25–1.22). The need to provide supplemental 
oxygen was reported in five studies, and analysis indicated 
that the provision of supplemental oxygen was comparable 
in the two groups (OR 0.74, 95% CI 0.52–1.03).
Other side effects
Seven studies reported bradycardia, with definitions varying 
from heart rates of ,50 beats/min to ,60 beats/min. Hypoten-
sion (systolic blood pressure varying from ,100 mmHg 
to ,80 mmHg) was reported in eight studies. The incidences 
of bradycardia (OR 1.18, 95% CI 0.84–1.65) and hypoten-
sion (OR 0.92, 95% CI 0.68–1.25) did not differ significantly 
between the two groups. Four studies reported the incidence 
of procedure termination secondary to concerns for patient 
safety, and there were no significant differences in early pro-
cedure termination (OR 4.96, 95% CI 0.24–104.39). Three 
studies reported patient satisfaction outcome and patient 
cooperation. Neither patient satisfaction (standard mean 
difference (SMD) −0.02, 95% CI −0.14 to 0.10) nor patient 
cooperation (SMD 0.00, 95% CI −0.12 to 0.11) differed 
significantly between the two groups.
Discussion
Recently, the use of sedatives has improved patient comfort 
and their acceptance of gastrointestinal endoscopy.21 Inter-
ventional endoscopic procedures under endoscopic sedation 
via a sedative agent such as propofol are now used widely.4 
During endoscopic sedation, cardiorespiratory complica-
tions such as hypoxemia and apnea may occur, and require 
technical monitoring including pulse oximetry. However, 
this method only provides an indirect measure of respiratory 
function, and the detection of cardiorespiratory depression 
may potentially be delayed.22
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Figure 3 Forest plot showing the odds ratios and 95% Cis of each study for severe hypoxemia.
Abbreviations: egD, esophagogastroduodenoscopy; CFs, colonoscopy.
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Capnography facilitates continuous, real-time, non-
invasive measurement of expiratory CO
2
. Capnography 
monitoring entails the measurement of end-tidal CO
2
 concen-
trations using an infrared sensor attached to a nasal cannula 
or face mask.12 This facilitates the early detection of arterial 
oxygen desaturation via near real-time graphic assessment 
of respiratory activity. Many studies of surgical operations 
and non-surgical procedures have shown that the use of 
capnography monitoring is associated with a reduction in 
the incidence of hypoxemic events. Nevertheless, the use 
of capnography during gastrointestinal endoscopy is not an 
established recognized standard for monitoring respiratory 
function.
In a recent meta-analysis,23 there was a lack of convinc-
ing evidence that the addition of capnography to standard 
monitoring in emergency departments reduced the rate of 
adverse events including hypoxemia. However, most of the 
procedures included in that analysis were orthopedic manipu-
lation, abscess incision and drainage, or cardioversion, which 
differ from elective procedures. In another meta-analysis 
including gynecologic procedures, abortion, and emergency 
department procedures,24,25 capnography reduced the rate of 
hypoxemia, which is consistent with the results of the current 
meta-analysis. Notably, there was no consensus on whether 
capnography could reduce the need for assisted ventila-
tion in those two studies. Further, there was no previously 
published meta-analysis of the use of capnography during 
gastrointestinal endoscopic sedation.
In previous sedation guidelines for non-anesthesiologists, 
continuous monitoring via visual observation of breathing 
and its frequency was recommended, but capnography 
monitoring was not mandatory.26 However, recent standards 
advocated by the American Society of Anesthesiologists 
suggest that the adequacy of ventilation should be evaluated 
via continuous capnography monitoring.27
The results of our meta-analysis show that capnography 
reduced the rate of hypoxemia during gastrointestinal 
sedation but was not significantly associated with incom-
plete endoscopic procedures or patient satisfaction. Many 
factors can influence respiratory depression, such as the 
degree and depth of sedation, the sedative agents used, the 
patient’s baseline disease status, age, and the duration of 
the procedure during endoscopy. The nine studies assessed 
in the current investigation evaluated hypoxemia, and the 
median procedure times of four studies were .30 minutes. 
The duration of the procedure is an important risk factor 
for oxygen desaturation. Therefore, it is expected that the 
role of capnography will increase in future in conjunction 
with the ongoing development of interventional endoscopy 
procedures with long procedure times, and the widespread 
use of sedatives associated with those procedures.
The results of the current investigation showed that cap-
nography has a beneficial effect by reducing the incidence 
of hypoxemia and severe hypoxemia during gastrointestinal 
endoscopic sedation. Because the target level of sedation 
was equal in both the standard monitoring and capnography 
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groups, the incidence of apnea was not different between the 
two groups; however, in two studies evaluating the detection 
of apnea, there was no evidence of heterogeneity and the 
results showed that apnea was more often detected with the 
addition of capnography than it was in the standard monitor-
ing group. Whereas most episodes of apnea might remain 
undetected using standard monitoring with visual assessment 
of the patient, the use of capnography can facilitate early 
interventions such as patient stimulation, withholding or 
reducing sedative medications, and using chin-lift or jaw-
thrust maneuvers. Easier detection of apnea via capnography 
may explain the difference in the incidence of hypoxemia 
between the two groups, and these results demonstrate the 
value of adding capnography monitoring during sedation for 
gastrointestinal procedure.
The target level of sedation in the trials included in this 
study ranged from moderate to deep sedation. In moderate 
sedation, spontaneous ventilation is adequate and mainte-
nance of airway patency does not require interventions.5 
However, it is not always possible to predict how a patient 
will respond to specific sedative and analgesic medications. 
Thus, the level of sedation could become deeper than initially 
intended. In this meta-analysis, the addition of capnography 
monitoring was effective in reducing hypoxemia, and it 
did not increase the rate of early procedure termination. 
Therefore, we suggest capnography monitoring should be 
considered for routine monitoring during gastrointestinal 
endoscopic procedures performed under moderate sedation 
in the future.
The present meta-analysis had several limitations that 
should be taken into account when interpreting the results. 
It included studies that varied with respect to the sedative 
agents and corresponding doses used. This may account 
for some of the heterogeneity in the results of the analysis. 
Second, because our analysis was based on only eight 
RCTs, we did not perform subgroup analysis based on the 
type of endoscopic procedure. Thus, it cannot be decisively 
concluded that diagnostic and therapeutic endoscopy have 
similar safety with regard to sedation. We also analyzed both 
upper endoscopy through the oral cavity and colonoscopy 
together. Further studies with larger numbers of patients are 
warranted to clarify the beneficial effects of capnography 
during gastrointestinal endoscopic sedation.
Conclusion
In the current meta-analysis, capnography monitoring was 
associated with reduced incidence of hypoxemia during gas-
trointestinal procedural sedation, and there was no evidence 
of an association with procedural interruption. Capnography 
monitoring should be considered in routine monitoring in 
the near future.
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